On this page
What is Dermatitis Herpetiformis (Duhring’s Disease)?
Dermatitis herpetiformis, also known as Duhring’s disease, is a rare skin condition that is closely and fundamentally linked to celiac disease. Understanding its name helps clarify what this condition actually involves:
-
Dermatitis: refers to inflammation of the skin
-
Herpetiformis: this descriptive term was coined after doctors observed the characteristic blisters and their clustered arrangement, which visually resembles the typical skin lesions seen in herpes virus infections. It is important to emphasize that despite the name, there is absolutely no relationship between dermatitis herpetiformis and the herpes simplex virus or the herpes zoster virus; the naming is based purely on visual resemblance, not shared cause
-
Duhring: honors the name of the physician, Louis Adolphus Duhring, who first clinically described this condition in the late 19th century
The condition manifests as the appearance of vesicular and bullous skin lesions, meaning a skin eruption characterized by small, raised bumps filled with clear fluid, which are intensely itchy and typically appear on the upper and lower limbs, particularly over the elbows and knees.
Dermatitis herpetiformis is particularly common between the ages of 30 and 40, and occurs more frequently in men than in women. The overall prognosis is generally very good when diagnosis and treatment are established promptly. In some cases, treatment can be limited to the strict elimination of gluten from the diet, although this dietary approach alone can initially be quite slow to produce noticeable improvement in symptoms. For this reason, treatment typically also includes dapsone, a medication originally developed for the treatment of leprosy, which has proven remarkably effective at rapidly resolving the symptoms of this particular type of dermatitis, often producing visible improvement within just a few hours of the very first dose.
Causes
Dermatitis herpetiformis primarily affects young and middle-aged adults, typically between 20 and 60 years of age, with the highest concentration of cases occurring between 30 and 40 years. The condition shows a clear predominance in males, with a male-to-female ratio of approximately 2 to 1. While less common, the disease can also occur in children.
The development of dermatitis herpetiformis is linked to a combination of:
- Genetic factors
- Environmental factors
Among the environmental factors, the most significant is the consumption of gluten, a protein found in certain cereal grains (including wheat, barley, and rye) that is responsible for triggering the characteristic immune reaction seen in celiac disease. On average, dermatitis herpetiformis is diagnosed in approximately 1 out of every 10 patients with celiac disease, though this proportion can vary considerably depending on the ethnic population studied.
Understanding the Autoimmune Mechanism
Dermatitis herpetiformis is fundamentally an autoimmune disease. Patients with this condition develop autoantibodies directed against transglutaminase enzymes, which are naturally present in the intestine and normally play a role in the digestion and processing of gluten.
These antibody-transglutaminase complexes, known as immune complexes, circulate throughout the bloodstream and eventually deposit within the skin. Once deposited, they activate the complement system, an essential component of the immune system that normally plays a crucial role in defending the body against infectious agents. In dermatitis herpetiformis, however, this activation occurs inappropriately within the skin, triggering the inflammatory cascade responsible for the disease’s characteristic symptoms.
Risk Factors
The primary and most significant risk factor for developing dermatitis herpetiformis is an underlying genetic predisposition. Certain genetic markers, particularly specific variants of genes involved in immune system regulation (similar to those associated with celiac disease itself), appear to substantially increase susceptibility to this condition.
Beyond genetics, several environmental factors can act as potential triggers for flare-ups in genetically susceptible individuals, including:
- Ingestion of iodides (compounds containing iodine), which have long been recognized as a potential trigger for skin flare-ups in susceptible patients
- Excessive gluten intake in the diet, which directly drives the underlying autoimmune process responsible for the disease
Transmission and Contagiousness
It is important to clearly emphasize that dermatitis herpetiformis is not a contagious disease. It cannot be spread from person to person through any form of contact. Instead, what can be inherited is a genetic predisposition to developing the condition, which can be passed down from parent to child, similar to the inheritance pattern seen in celiac disease itself.
Symptoms
The disease typically begins with a papulo-vesicular skin eruption, meaning it presents as a combination of raised skin lesions (papules) and raised, fluid-filled lesions with clear content (vesicles). These lesions are characteristically grouped together in clusters, similar to the pattern seen in herpes virus skin infections, which is precisely where the name “dermatitis herpetiformis” originates.
Occasionally, larger fluid-filled lesions called bullae may also be present, which similarly contain clear fluid but are larger in size compared to typical vesicles.
The itching associated with this condition is remarkably intense, and scratching frequently leads to skin excoriations (scratch marks) and crusting. Notably, symptoms of itching and burning typically precede the visible appearance of skin lesions by approximately 8 to 12 hours. The itching is so severe and persistent that dermatologists are often unable to examine truly intact, unscratched lesions during a clinical visit, as patients have usually already scratched the affected areas by the time they seek medical attention. Despite this intense scratching, healing generally occurs without the formation of permanent scars.
Typical Distribution of Skin Lesions
The characteristic lesions of dermatitis herpetiformis appear symmetrically (meaning on both sides of the body simultaneously) and are most commonly found on the extensor surfaces of the limbs, meaning the outer surfaces that straighten or extend the joint. Common locations include:
- The elbows
- The knees
- The buttocks
- The shoulder blade (scapular) region
- The lower back (sacral) region
The scalp, face, and hairline can also be involved, and some patients develop more extensive, widespread forms of the rash affecting the trunk of the body as well.
Involvement of the oral mucosa (inside the mouth), with the presence of vesicles or erosions, is relatively uncommon in dermatitis herpetiformis, distinguishing it from some other blistering autoimmune skin conditions where oral involvement is more typical.
The Connection With Celiac Disease
Celiac disease (gluten-sensitive enteropathy, an inflammatory condition affecting the small intestine) is found in nearly all patients diagnosed with dermatitis herpetiformis. However, remarkably, celiac disease remains clinically silent, or asymptomatic, in approximately 95% of these cases. In other words, a patient may experience the full, characteristic symptoms of dermatitis herpetiformis on their skin while having no noticeable digestive symptoms whatsoever, despite genuinely having underlying celiac disease affecting their intestines.
When celiac disease does produce noticeable symptoms, these typically include:
- Chronic diarrhea
- Abdominal pain
- Unintentional weight loss
Associated Autoimmune Conditions
Patients with dermatitis herpetiformis show a notably increased likelihood of also having other autoimmune diseases, reflecting a broader pattern of immune system dysregulation that appears to run through this patient population. These associated conditions include:
- Hashimoto’s thyroiditis, an autoimmune condition affecting the thyroid gland
- Type 1 diabetes mellitus, an autoimmune condition affecting insulin-producing cells in the pancreas
- Addison’s disease, an autoimmune condition affecting the adrenal glands
- Systemic lupus erythematosus, a systemic autoimmune condition that can affect multiple organs
- Sjogren’s syndrome, an autoimmune condition primarily affecting moisture-producing glands
- Sarcoidosis, an inflammatory condition that can affect multiple organ systems, particularly the lungs
- Vitiligo, an autoimmune condition causing loss of skin pigmentation
Given this significant association, doctors managing patients with dermatitis herpetiformis often maintain heightened awareness for signs and symptoms of these other autoimmune conditions during ongoing follow-up care.
Diagnosis
Establishing a definitive diagnosis of dermatitis herpetiformis requires taking a biopsy (tissue sample) of at least one recently developed, reddish papule (early skin lesion). Under microscopic examination, this tissue sample typically reveals a characteristic inflammatory infiltrate within the superficial dermis (the upper layer of skin beneath the epidermis), composed predominantly of neutrophils (a type of white blood cell), along with a smaller number of eosinophils (another type of white blood cell often associated with allergic and immune reactions). This inflammatory process causes a separation between the dermis and epidermis (the two main layers of skin), and accumulations of fibrin (a protein involved in clotting) and areas of tissue necrosis (dead cells) are also commonly observed.
Direct Immunofluorescence: The Key Confirmatory Test
The diagnosis is further confirmed and strengthened through direct immunofluorescence, a specialized laboratory technique. This method involves taking a skin sample from an area adjacent to an active lesion, but that itself appears clinically normal and unaffected (peri-lesional skin), and incubating this tissue with special antibodies designed to detect the presence of autoantibodies within the patient’s own skin.
In dermatitis herpetiformis specifically, direct immunofluorescence characteristically demonstrates granular deposits of IgA antibodies located at the tips of the dermal papillae (small, finger-like projections at the junction between the dermis and epidermis). Additionally, components of the complement system, specifically C3 and C5, can often also be detected in this same location, further supporting the diagnosis.
Differential Diagnosis
Dermatitis herpetiformis must be carefully differentiated from several other autoimmune blistering skin diseases based on their distinct clinical characteristics and, crucially, their differing direct immunofluorescence patterns. These conditions include:
- Bullous pemphigoid
- Pemphigus vulgaris
- Linear IgA dermatosis
Additionally, dermatitis herpetiformis must be distinguished from other inflammatory and infectious conditions that also cause intense itching, including:
- Atopic dermatitis
- Allergic contact dermatitis
- Papular urticaria (hives)
- Various forms of prurigo (chronic itchy skin conditions)
- Scabies, a parasitic skin infestation
Screening for Underlying Celiac Disease
Given the near-universal association between dermatitis herpetiformis and celiac disease, systematic screening for celiac disease should be performed in every patient diagnosed with dermatitis herpetiformis. This screening begins with blood tests measuring circulating levels of anti-gliadin antibodies and anti-transglutaminase antibodies of both the IgG and IgA classes, which serve as important serological (blood-based) markers of the disease.
However, a definitive diagnosis of celiac disease requires confirmation through a biopsy of the intestinal mucosa, specifically taken from the second or third portion of the duodenum (the first section of the small intestine). This tissue sample is obtained through a procedure called esophagogastroduodenoscopy (commonly referred to as an upper endoscopy), and the biopsy characteristically demonstrates flattening of the intestinal villi, the small, finger-like projections that normally line the small intestine and are essential for proper nutrient absorption.
Prognosis and Complications
Patients diagnosed with dermatitis herpetiformis show an increased prevalence of several other conditions that warrant ongoing medical attention, including various endocrine (hormonal) diseases, such as thyroid disorders, gastric atrophy (thinning of the stomach lining), Addison’s disease, and insulin-dependent (type 1) diabetes. There is also an increased prevalence of other autoimmune conditions, including systemic lupus erythematosus and Sjogren’s syndrome, and researchers have also proposed a potential association with vitiligo, sarcoidosis, and Bierman’s disease.
There is also a well-documented, though relatively modest increased risk of developing lymphomas affecting the digestive tract, as well as a slightly increased risk of leukemia. Importantly, this elevated cancer risk decreases substantially, and often disappears entirely, after approximately 5 years following diagnosis and the initiation of appropriate treatment. This favorable trend is believed to result largely from the beneficial, protective effect of maintaining a strict gluten-free diet over time.
Without appropriate treatment, dermatitis herpetiformis behaves as a chronic disease characterized by frequent flare-ups, which are typically triggered by exposure to iodine or by excessive gluten consumption.
Treatment
A strict gluten-free diet can, on its own, lead to complete resolution of dermatitis herpetiformis in many patients, and importantly, it also helps prevent the development of associated lymphomas discussed in the previous section. However, the response to dietary treatment alone tends to be quite slow, often taking many months to produce noticeable improvement in skin symptoms.
For this reason, dietary treatment is typically combined with medication, and the treatment of choice is diaminodiphenylsulfone, more commonly known as dapsone. This medication was originally developed for the treatment of leprosy, but has proven highly effective in dermatitis herpetiformis due to its anti-inflammatory and immune-modulating properties.
How Dapsone Is Used
Dapsone is effective specifically at treating the skin lesions associated with dermatitis herpetiformis, but importantly, it does not treat the underlying intestinal inflammation (enteropathy) caused by celiac disease, which is why the gluten-free diet remains an essential, complementary part of treatment even when dapsone is used.
The medication is administered orally, typically starting at a dosage of 100-150 mg per day, which is then gradually reduced over time down to a maintenance dose of approximately 50 mg twice weekly, once symptoms are well controlled. One of the most remarkable features of dapsone treatment is its speed of action: most patients experience noticeable symptom relief within just a few hours of taking their very first dose, which can be tremendously reassuring given the intense itching associated with this condition.
Important Safety Precautions
Before beginning dapsone therapy, it is absolutely essential to test the patient’s blood levels of an enzyme called glucose-6-phosphate dehydrogenase (G6PDH). This precaution is critical because in patients with a deficiency of this particular enzyme, dapsone can trigger varying degrees of hemolytic anemia (a condition involving the premature destruction of red blood cells), which can range from mild to potentially serious.
During the course of treatment, doctors must also carefully and regularly monitor the patient’s complete blood count and methemoglobin levels (a form of hemoglobin that cannot effectively carry oxygen), since dapsone can affect both of these blood parameters and requires ongoing laboratory surveillance to ensure treatment safety.
Alternative Treatment Options
If a patient does not tolerate dapsone well, due to side effects or other contraindications, an alternative medication called sulfapyridine can be used instead, though it is generally considered somewhat less effective and may require dose adjustments to achieve adequate symptom control.
Prevention
Currently, there are no established preventive measures available for this condition. Because dermatitis herpetiformis develops through a combination of underlying genetic predisposition and subsequent exposure to dietary gluten, and because the genetic component cannot be modified or prevented, there is no way to reliably prevent the condition from developing in genetically susceptible individuals.
That said, for individuals who have already been diagnosed with the condition, strict adherence to a gluten-free diet plays a crucial role in preventing disease flare-ups and reducing the long-term risk of associated complications, even though it cannot be considered a true “preventive” measure in the sense of stopping the disease from ever developing in the first place.
Living With Dermatitis Herpetiformis
Although dermatitis herpetiformis is a chronic condition, most patients achieve excellent long-term control of their symptoms with appropriate treatment, allowing them to lead entirely normal, healthy lives. A few practical considerations can help patients manage the condition effectively over time:
-
Commit fully to a gluten-free diet. Since gluten exposure is the central driver of this condition, strict and consistent avoidance of gluten-containing foods, even in small hidden amounts, is essential for long-term symptom control and for reducing associated health risks over time. Working with a registered dietitian experienced in celiac disease and gluten-free nutrition can be enormously helpful.
-
Be aware of hidden sources of iodine and gluten. Certain medications, supplements, and even some skin and hair products can contain iodine or gluten-derived ingredients that may trigger flare-ups in sensitive individuals. Reading labels carefully and discussing any new products or medications with your healthcare provider can help avoid unexpected triggers.
-
Attend regular follow-up appointments. Given the associations between dermatitis herpetiformis and other autoimmune and endocrine conditions, as well as the small increased risk of certain cancers, regular monitoring with your dermatologist and gastroenterologist is important for long-term health.
-
Understand that dapsone requires ongoing monitoring. If you are prescribed dapsone, regular blood tests will be necessary throughout treatment to ensure the medication continues to be both safe and effective for you.
-
Be patient with dietary treatment. While dapsone often provides very fast relief, remember that the gluten-free diet, which is essential for long-term disease control and eventual reduction or discontinuation of medication, works much more slowly and requires sustained commitment over many months.
Frequently Asked Questions
Can dermatitis herpetiformis go away completely?
Yes, many patients achieve complete and lasting resolution of their skin symptoms through strict, lifelong adherence to a gluten-free diet, sometimes eventually allowing for discontinuation of dapsone once the diet has had sufficient time to take full effect, though this should only be done under close medical supervision.
Is dermatitis herpetiformis the same as gluten intolerance or a wheat allergy?
No. Dermatitis herpetiformis is a specific autoimmune skin manifestation of celiac disease, involving IgA antibody deposits in the skin. It is distinct from non-celiac gluten sensitivity and from a true wheat allergy, both of which involve different immune mechanisms and different symptoms.
Do I need to avoid gluten forever if I have dermatitis herpetiformis?
Yes. Because dermatitis herpetiformis is directly linked to celiac disease, a lifelong, strict gluten-free diet is necessary, both to control skin symptoms and to protect against the intestinal damage and long-term complications associated with ongoing gluten exposure, even in the absence of noticeable digestive symptoms.
Why don’t I have digestive symptoms if I have celiac disease?
This is actually very common in dermatitis herpetiformis. Approximately 95% of patients with this condition have celiac disease that is clinically silent, meaning the intestinal damage is present and detectable on biopsy, but does not produce noticeable digestive symptoms such as diarrhea or abdominal pain.
How quickly does dapsone work for dermatitis herpetiformis?
Dapsone is remarkably fast-acting for this condition, with many patients experiencing significant relief from itching and new lesion formation within just a few hours of their first dose, a response time that is considered one of the more distinctive features of this treatment.
Can children develop dermatitis herpetiformis?
Yes, although it is more common in adults, particularly those between 30 and 40 years of age, dermatitis herpetiformis can occur in children as well, and should be considered in children with persistent, intensely itchy, blistering skin rashes, particularly if there is a personal or family history of celiac disease.
Sources and Bibliography
- Saurat J, Grosshans E, Laugier P, Lachapelle J. Dermatologia e malattie sessualmente trasmesse. Italian edition edited by Girolomoni G, Giannetti A. 3rd ed. Masson; 2006.
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Dermatitis Herpetiformis
- American Academy of Dermatology Association (AAD), Dermatitis Herpetiformis Overview
- Celiac Disease Foundation, Dermatitis Herpetiformis and Celiac Disease
- DermNet NZ, Dermatitis Herpetiformis
- National Center for Biotechnology Information (NCBI) / StatPearls, Dermatitis Herpetiformis Overview
- Mayo Clinic, Dermatitis Herpetiformis: Symptoms and Causes
